Earlier this month Sarepta announced a change in leadership, with CMO Ed Kaye taking over as interim CEO.
Following that announcement the team at Sarepta organized a call with Duchenne patient organizations and foundations to update them on the transition.
The messages were very clear from the call:
Everything is still moving forward - they are all about continuity.
There is a renewed passion…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this